Fazal Hadi | Pharmaceutical Sciences | Best Researcher Award

Published on by Academic Awards

Dr. Fazal Hadi | Pharmaceautical sciences | Best Researcher Award

Dr. Fazal Hadi, Abdul Wali Khan University Mardan, Pakistan

Dr. Fazal Hadi is a dedicated hospital pharmacist and emerging researcher from Mardan, Pakistan. Currently pursuing his PhD in Pharmaceutical Sciences at AWKUM, he specializes in pharmacology, phytochemistry, and drug interaction studies. With hands-on experience as a pharmacist at MERF hospitals and academic roles as a visiting lecturer and research assistant, Dr. Hadi blends practical expertise with academic excellence. He has authored multiple publications in reputed journals and actively participates in scientific conferences. Fluent in Pashto, Urdu, and English, he is passionate about improving patient care through innovative pharmaceutical research.

Publication Profile

Orcid

Google Scholar

πŸ§ͺ Professional Experience

Dr. Fazal Hadi brings extensive pharmaceutical and academic experience to his role in healthcare and research. As a Visiting Lecturer at AWKUM (2025–present), he engages students with lectures and guides scholarly work. From 2022–2024, he worked as a Research Assistant, mastering techniques like PCR, RNA extraction, and in vivo assays. Concurrently, he served as a Pharmacist at MERF hospitals in Peshawar, ensuring drug stock management and patient care. Earlier roles include service at a COVID-19 hospital and GIK Institute. His leadership as Pharmacy Store In-Charge during the “Sihat ka Insaaf” campaign in 2015 further highlights his dedication.

πŸŽ“ Educational Background

Dr. Fazal Hadi has pursued a progressive academic journey in pharmaceutical sciences. He is currently enrolled in a Ph.D. in Pharmaceutical Sciences at AWKUM, Mardan (2026, in progress) πŸ§ͺ. He completed his MPhil in Pharmacology from Abasyn University, Peshawar in 2019 with a CGPA of 3.27/4 πŸ“Š. He earned his Doctor of Pharmacy (Pharm D) from Gandhara University, Peshawar in 2014 with First Division πŸ’Š. Additionally, he holds a Bachelor of Arts in Sociology from AWKUM (2011) and completed FSc (Pre-medical) at Islamia College, Peshawar (2008, A+ grade) and Matriculation in Science in 2006 with an A1+ grade

πŸ”¬ Research Focus

Dr. Fazal Hadi’s research primarily revolves around pharmacology, ethnopharmacology, and natural product chemistry 🌿. His work emphasizes the therapeutic potential of medicinal plants, focusing on their analgesic, antipyretic, anthelmintic, antidiabetic, and nutritional properties 🌱🧬. He also investigates food–drug interactions, as shown in his pharmacokinetics research on grape juice and omeprazole πŸ₯€πŸ’Š. His studies bridge traditional medicine with modern pharmacological validation, contributing to safe and effective drug discovery. By integrating in vivo, in vitro, and molecular techniques, his research supports innovation in herbal medicine, clinical pharmacy, and pharmaceutical sciences

Publication Top Notes

πŸ“„ “Integrating In Vitro, Network Pharmacology, and Molecular Docking Approaches to Uncover the Antidiabetic Potential of Tylophora hirsuta“ – Computational Biology and Chemistry, 2025Β 
πŸ“„ “Unveiling the Therapeutic and Nutritious Potential of Vigna unguiculata in Line with its Phytochemistry” – Heliyon, 2024 | Cited by: 10 🌱🧬
πŸ“„ “Vigna mungo (Linn.) Hepper: Ethnobotanical, Pharmacological, Phytochemical, and Nutritious Profile” – Phytochemistry Reviews, 2024 | Cited by: 1 πŸŒΏπŸ“š
πŸ“„ “In Vivo Investigations of Analgesic, Antipyretic and Anthelmintic Activities of Various Extracts of Fernandoa adenophylla“ – Pharmaceutical Chemistry Journal, 2021 | Cited by: 4 πŸ§«πŸ’Š
πŸ“„ “Impact of Fresh Grape Juice on the Pharmacokinetics of Omeprazole: Results of a Food–Drug Interaction Study” – Frontiers in Pharmacology, 2024

Sadia Kashif | Pharmacology | Best Researcher Award

Published on by Academic Awards

Assist. Prof. Dr. Sadia Kashif | Pharmacology | Best Researcher Award

Assistant Professor at Ziauddin University, Pakistan

Dr. Sadia Suri Kashif is a dedicated pharmacologist and academic with a Ph.D. in Pharmacology from the University of Karachi. With extensive experience in teaching, research, and academic leadership, she currently serves as an Assistant Professor at Ziauddin University. Her work emphasizes interdisciplinary collaboration and the pursuit of impactful research in pharmacology and health sciences. She actively contributes to scholarly publications, supervises M.Phil research, and engages in academic editorial roles. Known for her innovation in herbal fertility treatments, Dr. Sadia continues to inspire future pharmacists through both classroom teaching and cutting-edge research. πŸŒΏπŸ“š

Publication Profile

Orcid

Educational Background

Dr. Sadia Suri Kashif holds a Ph.D. in Pharmacology (2024) with a GPA of 4.0 from the University of Karachi, reflecting her academic excellence and commitment to scientific advancement. She earned her M.Phil in Pharmacology from the same institution in 2008 with a GPA of 3.50, and her foundational B. Pharmacy degree in 2003 with a GPA of 3.26. Her educational journey has been marked by distinction and a focus on research-based learning, laying the groundwork for her contributions to pharmacological education and therapeutic research. πŸŽ“πŸ“–πŸ’Š

Professional Background

With over 15 years of academic and research experience, Dr. Sadia Suri Kashif has taught at prestigious institutions like Ziauddin University and Nazeer Hussain University. Currently serving as Assistant Professor since 2017, she teaches Pharmacology, Physiology, and Anatomy, and leads academic publications like PharmaZia and Pharma Vision. Her earlier roles include Lecturer at Jinnah University and freelance research writer. She also interned at Aga Khan University Hospital. Dr. Sadia is widely respected for her teaching, mentoring, and administrative skills in higher education. πŸ‘©β€πŸ«πŸ”¬πŸ“„

Awards and Honors

Dr. Sadia Suri Kashif has earned recognition for her multifaceted contributions to pharmaceutical education and research. She has presented research at national and international conferences and actively contributes to academic journals as a reviewer for Discover Toxicology and others. Her leadership roles in organizing workshops and conferences, alongside research excellence, have positioned her as a respected voice in pharmacology. She was involved in patent submissions for herbal fertility treatments and has been consistently acknowledged by academic peers for her commitment to innovation and student mentorship. πŸ†πŸ“œπŸŒŸ

Research Focus

Dr. Sadia Suri Kashif’s research centers on pharmacological solutions for infertility, depression, and anxiety, with a strong emphasis on animal models and plant-based therapies. Her current projects explore herbal compositions like Allium cepa and Juglans regia for reproductive health. She supervises M.Phil scholars, evaluates antimicrobial agents, and studies neuroactive compounds. Her two-generation studies in rats have received international publication and recognition. With multiple patents under review, her research aims to merge traditional medicine with modern pharmacology for therapeutic advancement. 🌱πŸ§ͺ🧠

Publication Top Notes

1. Fertility‐Enhancing Potential of P. amygdalas and J. regia Oil Mixture in Wistar Rats: Male/Female Infertility Models Assessment
Year: 2025

2. Fertility-enhancing effects of Prunus amygdalas oil on reproductive functions of male rats: A two-generation study
Year: 2025

3. CLINICAL EFFECTIVENESS OF INSULIN GLARGINE & ASPART VERSUS NPH & REGULAR INSULIN RÉGIME IN TYPE 1 DIABETIC PATIENTS OF PAKISTAN
Year: 2024

4. Emerging Role of Medicinal Herbs on Alzheimer’s Disease and Memory Deficits
Year: 2024

5. Depression Review: Factors and Perspectives
Year: 2019

Conclusion

Dr. Sadia Kashif is a highly accomplished researcher in the fields of pharmaceutical and biomedical sciences, with over 25 peer-reviewed publications in reputable journals such as PLOS One, Avicenna Journal of Phytomedicine, and Metabolic Brain Disease. Her work demonstrates exceptional diversity and innovation, focusing on plant-based therapeutics, reproductive pharmacology, and neuroscience, often using both in-vivo and in-vitro models. She has two patents under review related to herbal remedies for reproductive health, reflecting a strong translational impact. In addition to her research productivity, Dr. Kashif is an active academic mentor, journal reviewer, and contributor to scientific forums and editorial platforms. Her interdisciplinary and socially relevant research, combined with her professional engagement and academic service, make her a deserving candidate for the “Best Researcher Award.”

 

 

Shubham Sharma | Pharmacology | Best Researcher Award

Published on by Academic Awards

Shubham Sharma | Pharmacology | Best Researcher Award

Dr Shubham Sharma, Pfizer, United States

Dr. Shubham Sharma is a leading computational modeler with 8+ years of expertise in theoretical materials science, physics, and chemistry. Holding a Ph.D. in Chemical & Environmental Engineering from Brown University (2021), he specializes in atomistic modeling and solid-form design, notably working at Pfizer where he leads drug de-risking efforts. His research in catalysis, electrochemistry, and crystal structure predictions has earned him over 10 Pfizer Bravo awards. Dr. Sharma’s groundbreaking work is recognized globally, including invited talks at major conferences, advancing both pharmaceutical and renewable energy applications. πŸ’»πŸ”¬πŸ’Šβš‘

Publication Profile

Google Scholar

Education

This individual holds a PhD in Chemical & Environmental Engineering from Brown University, USA (2016-2021) πŸŽ“, where they conducted research under the guidance of Andrew A. Peterson πŸ§‘β€πŸ”¬. Their academic journey began with a Bachelor of Technology (B. Tech) in Chemical Engineering from the Heritage Institute of Technology, India (2012-2016) πŸ› οΈ. With a strong foundation in chemical engineering, they have pursued advanced studies focusing on environmental solutions and sustainability 🌍. Their education showcases a dedication to addressing global environmental challenges through innovative engineering approaches and cutting-edge research πŸŒ±πŸ“˜.

Work Experience

Currently serving as a Senior Scientist in Computational Materials Science at Pfizer Inc. (July 2022 – present) πŸ§‘β€πŸ”¬, this individual leads the Solid Form Design Center (SFDC) focused on de-risking potential drug molecules through advanced statistical and quantum mechanical modeling πŸ’Š. They contributed to the success of Zavegepant (Zavzpretβ„’) and Rimegepant (Nurtecβ„’) 🌟. As a core member of the Crystal Structure Prediction team, they specialize in electronic structure theory, density functional theory, and atomistic modeling 🧬. They also collaborate with global industrial and academic partners, lead multiple research proposals, and mentor colleagues in computational science πŸ”¬πŸ’».

Selected conference presentations

Sharma has delivered numerous invited talks and presentations globally 🌍. In 2024, they presented on multi-polymorphic systems at the Crystal Form Consortium Symposium (UK) and computational strategies in pharmaceutical research at UConn (US) and IISER (India) πŸ§ͺ. Sharma also discussed electrocatalysis at the 8th Global Webinar on Materials Science & Engineering in 2023 πŸ§‘β€πŸ«. Other notable presentations include de-risking medicines at AAPS NERDG (2024) and several studies on oxygen reduction reactions and catalytic properties at AIChE, NECS, ECS, and MRS conferences 🎀. Their work spans computational modeling and applied research in materials science and electrocatalysis βš›οΈ.

Research Focus

The research focus of Sharma spans electrochemistry, catalysis, and materials science. Sharma investigates the design and stability of catalysts, particularly Pt-based and CoPt alloys, for fuel cells and oxygen reduction reactions (ORR) βš‘οΈπŸ”‹. His work includes dynamic stability, reaction barriers, and potential-controlled reactions, using advanced techniques like density functional theory (DFT) and experimental-theoretical integration. He also explores solid form derisking in pharmaceuticals πŸ’Š and carbon electrodes in redox flow batteries. Sharma’s studies contribute to cleaner energy and advanced catalytic systems πŸŒπŸ”¬, emphasizing electrochemical stability and performance improvement in energy devices.

 

Publication Top Notes

Hard-magnet L10-CoPt nanoparticles advance fuel cell catalysis

Anisotropic Strain Tuning of L10Β Ternary Nanoparticles for Oxygen Reduction

Face-centered tetragonal (FCT) Fe and Co alloys of Pt as catalysts for the oxygen reduction reaction (ORR): A DFT study

Ordered CoPt oxygen reduction catalyst with high performance and durability

Metal dissolution from first principles: Potential-dependent kinetics and charge transfer

Assessment of carbon monoxide exposure in roadside food-vending shanties using coal cookstoves in Kolkata, India

Dynamic stability of Pt-based alloys for fuel-cell catalysts calculated from atomistics

Conclusion

Dr. Shubham Sharma’s innovative research in computational modeling and materials science, alongside his leadership in both academic and industrial collaborations, makes him an exceptional candidate for the Best Researcher Award. His contributions have not only advanced pharmaceutical drug design but also impacted renewable energy research, marking him as a distinguished leader in his field.

Vahideh Mohammadzadeh | Pharmacology Award | Best Researcher Award

Published on by Academic Awards

Dr. Vahideh Mohammadzadeh | Pharmacology Award | Best Researcher Award

Dr. Vahideh Mohammadzadeh, mashhad university of medical science, Iran

Dr. Vahideh Mohammadzadeh is a Ph.D. student in Pharmaceutical Nanotechnology at Mashhad University of Medical Sciences, Iran. Her research focuses on innovative drug delivery systems like nanoliposomes for treating cancer and eye diseases. With expertise in nanoformulations (liposome, micelle, polymer), she conducts in-vitro assays and specializes in MTT assay and HPLC. Her work spans biochemistry, immunology, and nanomedicine, highlighted by numerous publications on nanosensors, therapeutic nanoparticles, and drug delivery advancements. Dr. Mohammadzadeh is also skilled in statistical analysis, technical writing, and communication. She aims to revolutionize healthcare through cutting-edge pharmaceutical nanotechnology. πŸ“šπŸ’Š

 

Publication Profile

Professional Background

Dr. Vahideh Mohammadzadeh is currently pursuing her Ph.D. in Pharmaceutical Nanotechnology at Mashhad University of Medical Sciences, Iran. Her research primarily focuses on advancing drug delivery systems, particularly through nanotechnology. She specializes in the formulation of nanoliposomes and other nanostructures like micelles and polymers for targeted therapy in cancer and ocular diseases. Dr. Mohammadzadeh has extensive experience in conducting in-vitro biochemical and immunological assays, including MTT assay and HPLC analysis. Her work is underscored by a prolific publication record encompassing topics such as nanosensors, therapeutic nanoparticles, and innovative drug formulations. πŸ“ŠπŸ”¬

Education

Ph.D., Pharmaceutical Nanotechnology, Mashhad University of Medical Sciences, 2018-2024

M.Sc., Toxicology, Mashhad University of Medical Sciences, 2014-2017

B.Sc., Biology

Research Focus

Dr. Vahideh Mohammadzadeh’s research primarily focuses on advancing drug delivery systems in cancer therapy through innovative nanotechnologies. Her work spans the development and characterization of nanoliposomes, polymeric micelles, and other nanostructures to enhance the targeted delivery of therapeutic agents for cancer and ocular diseases. She explores novel formulations like liposomes and plant-based nanoparticles to optimize drug efficacy while minimizing side effects. Dr. Mohammadzadeh’s research also delves into nanosensors for biomolecule detection and the biological synthesis of nanoparticles for cytotoxicity studies. Her contributions aim to revolutionize healthcare through cutting-edge nanomedicine solutions. πŸŒŸπŸ”¬

 

Publication Top Notes

  • Poly-Ξ³-glutamic acid nanoparticles as adjuvant and antigen carrier system for cancer vaccination πŸ“„ Citations: 14 | Cited by: Jaafari, M.R. et al. | Year: 2023
  • Plant Gel-Mediated Synthesis of Gold-Coated Nanoceria Using Ferula gummosa: Characterization and Estimation of Its Cellular Toxicity toward Breast Cancer Cell Lines πŸ“„ Citations: 14 | Cited by: Sarafraz Ardakani, M.R. et al. | Year: 2023
  • Icariin: A Promising Natural Product in Biomedicine and Tissue Engineering πŸ“„ Citations: 22 | Cited by: Simal-Gandara, J. et al. | Year: 2023
  • Correction to: New insights into the application of nanoghosts as theranostic tools with an emphasis on cardiovascular diseases πŸ“„ Citations: 1 | Cited by: Qindeel, M. et al. | Year: 2022
  • Novel EPR-enhanced strategies for targeted drug delivery in pancreatic cancer: An update πŸ“„ Citations: 21 | Cited by: Sibuh, B.Z. et al. | Year: 2022
  • Fluorescent-based nanosensors for selective detection of a wide range of biological macromolecules: A comprehensive review πŸ“„ Citations: 106 | Cited by: DΓ­ez-Pascual, A.M. et al. | Year: 2022
  • Applications of plant-based nanoparticles in nanomedicine: A review πŸ“„ Citations: 84 | Cited by: Varma, R.S. et al. | Year: 2022
  • Biological synthesis and characterization of gold nanoparticles using Verbascum speciosum Schrad. and cytotoxicity properties toward HepG2 cancer cell line πŸ“„ Citations: 35 | Cited by: Nadaf, M. et al. | Year: 2022
  • Theranostic advances of bionanomaterials against gestational diabetes mellitus: A preliminary review πŸ“„ Citations: 24 | Cited by: Thakur, V.K. et al. | Year: 2021